Current position:Home >Product >
1,11,12-trihydroxy-2,16-dioxo-11,20-epoxypicras-3-en-15-yl 2-methylbut-2-enoate
1,11,12-trihydroxy-2,16-dioxo-11,20-epoxypicras-3-en-15-yl 2-methylbut-2-enoate(59866-88-5)
- Name: 1,11,12-trihydroxy-2,16-dioxo-11,20-epoxypicras-3-en-15-yl 2-methylbut-2-enoate
- Synonyms:
- Molecular Formula:C25H32O9
- Molecular Weight:476.5162
- CAS Registry Number:59866-88-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.59866-88-5 GLAUCARUBOLONE-15-TIGLATE
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] CAS No.59866-88-5 59866-88-5
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)]
Other Product
- 50347-36-9/bismuth(3+) hydroxide 5-nitroquinolin-8-olate (1:2:1)
- 97338-10-8/methyltris[2-oleoylethyl]ammonium methyl sulphate
- 15930-66-2/3-(octyloxy)propylamine
- 14643-87-9/Zinc acrylate
- 98534-23-7/N-cyclopropyl-1-(2,4-dichlorophenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxamide
- 36286-18-7/(5,6-dimethoxy-3-oxo-2,3-dihydro-1H-inden-1-yl)acetic acid
- 38683-48-6/Allyl, pentafluoro-, radical
- 52298-44-9/4-Amino-2,5-dimethoxy-N-phenylbenzenesulphonamide
- 24567-76-8/Color developing agent CD-3
- 131962-73-7/N-[2-(2-hydroxy-2-phenylethoxy)ethyl]-N-methyl-5-oxoprolinamide
- 202852-57-1/2H-Cyclopenta[a]pentalen-2-one,1,3b,4,5,6,6a,- 7,7a-octahydro-7-hydroxy-3,5,5,7a-tetramethyl-,(3bR,6aS,7S,7aS)-rel-(-)-
- 83487-96-1/9-Undecenoic acid, 11-(2-(9-((2-((2-((2-aminoethyl)amino)ethyl)amino)ethyl)amino)-9-oxononyl)-5,6-dipentyl-2-cyclohexen-1-yl)-
- 82320-99-8/3H-Phenoxazine-1,9-dicarboxamide,2-amino- N,N'-bis[5-[[[3-(dimethylamino)propyl]amino]- carbonyl]-1-methyl-1H-pyrrol-3-yl]-4,6- dimethyl-3-oxo-
- 16584-45-5/1-Hydroxy-2-methoxy-10-methyl-3-[(3-methyl-2-butenyl)oxy]acridin-9(10H)-one
- 103291-43-6/6H-Pyrimido[4,5-b][1,4]benzothiazine-4,9-diamine,7,8-dihydro-N4,N4,7,7-tetramethyl-N9-pentyl-, hydrobromide (1:1)
- 83291-73-0/3-[({2-[(2-{4-[(3-amino-2,3,6-trideoxyhexopyranosyl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl}-2-oxoethyl)sulfanyl]ethyl}sulfanyl)acetyl]-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-a
- 65086-70-6/1,1'-(octadecadienylimino)bispropan-2-ol
- 18709-08-5/5-({[(2E,6E)-9-(3,3-dimethyloxiran-2-yl)-3,7-dimethylnona-2,6-dien-1-yl]oxy}methyl)-1,3-benzodioxole
- 78361-94-1/Naphthoquinoline
- 59866-88-5/1,11,12-trihydroxy-2,16-dioxo-11,20-epoxypicras-3-en-15-yl 2-methylbut-2-enoate
- 59000-17-8/1-[4-(methylsulfanyl)phenyl]urea
- 178979-12-9/{1-ethyl-4-(1-methylethyl)-5-[(3-nitrophenyl)sulfanyl]-1H-imidazol-2-yl}methanol
- 117287-39-5/Benzenesulfonic acid,4-[3-ethyl-4-[5-(hexahydro-2,4,6-trioxo-1,3-dipentyl-5-pyrimidinyl)-2,4-pentadien-1-ylidene]-4,5-dihydro-5-oxo-1H-pyrazol-1-yl]-
- 67935-93-7/5-[(dichloroacetyl)amino]-2,4-bis[(E)-{4-[(3,4-dimethyl-1,2-oxazol-5-yl)sulfamoyl]phenyl}diazenyl]naphthalen-1-yl dichloroacetate
- 157629-62-4/Peptide YY II (rabbit)(9CI)
- 75026-29-8/Olean-12-en-28-oic acid,3-[(O-6-deoxy-R-L-mannopyranosyl- (1f2)-O-6-deoxy-R-L-mannopyranosyl- (1f2)-O-â-D-xylopyranosyl-(1f2)-R-Larabinopyranosyl) oxy]-23-hydroxy-,â-Dglucopyranosyl ester,(3â,4R)-
- 140412-83-5/10-ethyl-10,11-dihydrodibenzo[b,f][1,4]oxazepine
- 17408-56-9/5-phenyl-3-(phenylamino)furan-2(5H)-one
- 100007-56-5/Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one,9-[[4,6-O-(1R)-ethylidene-b-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-,(5R,5aS,8aR,9S)-
- 67596-04-7/(3-chloro-2-hydroxypropyl)dimethyl[2-[(2-methyl-1-oxoallyl)oxy]ethyl]ammonium nitrate